HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.

Abstract
Umbilical cord blood transplantation is applied as treatment for mainly pediatric patients with hematologic malignancies. The clinical results show a relatively low incidence of graft-versus-host disease and leukemia relapse. Since maternal cells traffic into the fetus during pregnancy, we questioned whether cord blood has the potential to generate cytotoxic T cells specific for the hematopoietic minor histocompatibility (H) antigen HA-1 that would support the graft-versus-leukemia effect. Here, we demonstrate the feasibility of ex vivo generation of minor H antigen HA-1-specific T cells from cord blood cells. Moreover, we observed pre-existing HA-1-specific T cells in cord blood samples. Both the circulating and the ex vivo-generated HA-1-specific T cells show specific and hematopoietic restricted lysis of human leukocyte antigen-A2(pos)/HA-1(pos) (HLA-A2(pos)/HA-1(pos)) target cells, including leukemic cells. The cord blood-derived HA-1-specific cytotoxic T cells are from child origin. Thus, the so-called naive cord blood can comprise cytotoxic T cells directed at the maternal minor H antigen HA-1. The apparent immunization status of cord blood may well contribute to the in vivo graft-versus-leukemia activity after transplantation. Moreover, since the fetus cannot be primed against Y chromosome-encoded minor H antigens, cord blood is an attractive stem cell source for male patients.
AuthorsBregje Mommaas, Janine A Stegehuis-Kamp, Astrid G van Halteren, Michel Kester, Jürgen Enczmann, Peter Wernet, Gesine Kögler, Tuna Mutis, Anneke Brand, Els Goulmy
JournalBlood (Blood) Vol. 105 Issue 4 Pg. 1823-7 (Feb 15 2005) ISSN: 0006-4971 [Print] United States
PMID15498856 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes, T-Lymphocyte
  • HA-1 antigen
  • HLA-A2 Antigen
  • Minor Histocompatibility Antigens
  • Oligopeptides
Topics
  • Cell Differentiation (immunology)
  • Cell Line
  • Cell Line, Tumor
  • Cell Separation
  • Cells, Cultured
  • Cytotoxicity, Immunologic
  • Epitopes, T-Lymphocyte (immunology)
  • Female
  • Fetal Blood (cytology, immunology, metabolism)
  • Fetus (cytology, immunology, metabolism)
  • HLA-A2 Antigen (biosynthesis)
  • Hematopoietic Stem Cells (cytology, immunology)
  • Humans
  • Maternal-Fetal Exchange (immunology)
  • Minor Histocompatibility Antigens (biosynthesis, blood, immunology)
  • Oligopeptides (biosynthesis, blood, immunology)
  • Pregnancy
  • T-Lymphocyte Subsets (immunology, metabolism)
  • T-Lymphocytes, Cytotoxic (cytology, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: